TUBA1C and glioblastoma: These results were confirmed in TCGA RNA sequencing data (Figure 1E), (Figure 2A, 2E), which further suggested that higher expressions of CDK4/CDK6, TUBA1C were accompanied by higher malignancy in glioblastomas.